Checkpoint Therapeutics Receives Approval for PD-L1 Therapy December 16, 2024 The approval of cosibelimab-ipdl provides an option for patients with cutaneous squamous cell carcinoma December 13, 2024 (Sacramento, California) The…
Concerned About Skin Cancer? Here’s What You Should be Asking Your Dermatologist December 5, 2023 Your skin is your body’s first line of defense. Taking care of it is essential, especially when it comes to…
Jun. 10, 2026 The FDA Just Approved a New Sunscreen Ingredient— What It Means for Patients with Skin Cancer, Survivors, and the General Public
Jun. 03, 2026 Why Are Young People Tanning Again? What a New allure Feature Reveals About Melanoma Prevention Challenges